Browse by category

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery more difficult, according to new research being presented at the European Congress on Obesity (ECO) in Istanbul, Turkey. "Our findings suggest that prediabetes is associated with persistent changes in fat tissue that may limit its ability to fully adapt after weight loss," said author, Dr Camila Milad from Hospital Clinic de Barce

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, according to one of the first real-world studies to examine dietary behaviour in people using glucagon-like peptide-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual agonists RAs (collectively referred to as GLP-1 RAs) with the help of an AI-pow

Johnson & Johnson has announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System – a prospective, multi-centre clinical study evaluating the safety and performance of the system in Roux-en-Y gastric bypass (RYGB) procedures. The results were presented at the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting. “The data show encouraging evidence regarding the safety and performance of the OTTAVA™ Robotic

Bariatric News spoke with Professor Paulina Salminen, a professor of surgery and gastrointestinal surgery at University of Turku and Turku University Hospital in Finland, and President of the European Chapter of the International Federation For Surgery and Other Therapies for Obesity (IFSO-EC/IFSO), about her career path, her commitment to evidence-based research, and the challenges facing metabolic and bariatric surgery (MBS)... Why did you decide to enter medicine? Initial

For nearly two decades, Professor Michel Gagner (Professor of Surgery in Montreal, Canada) has been working on new technologies to eliminate the limitations and complications associated with staplers and sutures. His innovative solution is magnetic compression anastomosis. In this interview he discusses the evolution of the technology, the positive outcomes, the latest data to be presented in Malaga and why he believes it could revolutionise the future if gastro-intestinal (G

The British Obesity & Metabolic Specialist Society (BOMSS) recently revealed that endoscopic sleeve gastroplasty (ESG) procedural data will be incorporated into the Society’s National Bariatric Surgery Registry (NBSR). In this interview, Mr Omar Khan, Chair of the NBSR Committee, and Mr Jamie Kelly, who has performed over 500 ESG procedures, discuss the importance of the registry, why ESG plays a crucial role in the armamentarium of a bariatric specialist and the future possi

More than one billion people worldwide are living with obesity. Lifestyle intervention programmes, GLP-1 medications and bariatric surgery can be transformative, but they do not exist in a nutritional vacuum. Deficiencies are common among people affected by obesity before treatment begins, and surgery or medication can make them harder to ignore. Patients arrive underprepared, find little nutritional support built into their care, and are largely left to manage the consequenc

Both metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonist (GLP-1RA) medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk, according to a study by researchers from the Mayo Clinic. Importantly, researchers say the findings are not about choosing one treatment over another, but about better aligning treatment decisions with long-term healt

Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness, according to a preclinical study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The study showed that each time overweight mice stopped and restarted GLP-1s, they dropped less and less weight compared their original weight-loss. “The effectiveness of these medications may depend heavily on consistency,” said Dr

Olympus Corporation has received FDA 510(k) clearance for the POWERSEAL Open Extended Jaw Sealer/Divider. This latest edition to the Olympus POWERSEAL advanced bipolar surgical energy portfolio supports clinical needs for precision, efficiency and control during surgery. POWERSEAL Open Extended Jaw Sealer/Divider The POWERSEAL Open Extended Jaw Sealer/Divider joins three 5mm devices in the POWERSEAL portfolio. These 5mm devices are offered in three jaw configurations, each av